MedTrace Logo

A Multidisciplinary Intervention Including a Clinical Decision Support System and an App for Drug Therapy Management in Older Patients

NCT04391218 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2021-03-05

No results posted yet for this study

Summary

"La Casa nel Parco" (CANP) Project is a European Union and Regione Piemonte funded multidisciplinary project aimed to explore innovative technology application in older subject care. In this context, FARMA-CANP is a randomized open-label clinical trial evaluating a multidisciplinary intervention in older patients hospitalized at home. The intervention involves physicians, pharmacists, nurses and includes a Clinical Decision Support System to help the processes of therapeutic review and reconciliation, and an end-user App to support patients and/or caregivers in the daily management of drug therapy.

The main objectives of the study are to evaluate the impact of the intervention on 1) medication adherence after discharge 2) medication appropriateness.

Conditions

  • Polypharmacy
  • Multimorbidity
  • Aged

Interventions

OTHER

Multidisciplinary Approach Group

Geriatricians will introduce medication review data on a Clinical Decision Support System, that will help both pharmacists and physicians in medication reconciliation, highligting potentially inappropriate prescriptions according to Beers' criteria and STOPP/START criteria, and potential controindicated and major Drug-Drug Interactions according to Micromedex. Before Hospital at Home discharge, nurses will instruct patients and/or caregivers to the use of an App, where daily drug therapy at discharge will be inserted and scheduled. This App will automatically create an alert everytime a drug dose needs to be taken, alongside an image of the specific drug packaging. The App will register if and when the patient actually takes the drug, or the reason for the delayed/missed dose.

Sponsors & Collaborators

  • University of Turin, Italy

    collaborator OTHER

  • Infologic S.r.l., Padova, Italy

    collaborator UNKNOWN

  • Consoft Sistemi S.p.A. Turin, Italy

    collaborator UNKNOWN

  • ASL Città di Torino, Italy

    collaborator UNKNOWN

  • A.O.U. Città della Salute e della Scienza

    lead OTHER

Principal Investigators

  • Renata Marinello, MD, PhD · A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-31
Primary Completion
2021-05-31
Completion
2021-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04391218 on ClinicalTrials.gov